Molecular diagnostics laboratory P23 Labs reported on Friday the availability of its new P23 Respiratory ONE test to detect respiratory illnesses that share symptoms with COVID-19 when test results for COVID-19 are negative and the patient is still not healthy.
The company added that the P23 Respiratory ONE can detect the common cold, five different Influenza strains and five Coronavirus strains including COVID-19. The test results are available 48 hours from lab receipt.
According to the company, the P23 Respiratory ONE takes a single COVID-19 sample, whether it is the non-invasive saliva sample or the nasal swab sample. The kits are shipped directly to patients to allow sample collection from the comfort of their own home.
If anyone is presenting COVID-19 symptoms and working with their physician to obtain a COVID-19 order, the patient should also tell their physician that they would like to have a test that identifies what illness they do have if it is not COVID-19, concluded the company.
UCB announces BIMZELX (bimekizumab-bkzx) three-year data at EULAR 2025
Sanofi expedites Beyfortus shipments to support early RSV season readiness
Mediar Therapeutics reports first IPF patient dosed in MTX-463 Phase 2 trial
Innovent's IBI363 granted second breakthrough therapy designation in China
bioMérieux launches rapid PCR test for equine respiratory diseases
BioNTech and Bristol Myers Squibb partner to co-develop bispecific antibody for solid tumours